{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:27:03Z","timestamp":1752229623267},"reference-count":47,"publisher":"FapUNIFESP (SciELO)","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1590\/s1678-9946201759005","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T23:13:43Z","timestamp":1491434023000},"source":"Crossref","is-referenced-by-count":7,"title":["Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis from the Brazilian Amazon"],"prefix":"10.1590","volume":"59","author":[{"given":"Massanobu","family":"Takatani","sequence":"first","affiliation":[{"name":"Universidade Federal do Amazonas, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myuki Esashika","family":"Crispim","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Hospitalar de Hemoterapia e Hematologia do Amazonas, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Fraiji","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Hospitalar de Hemoterapia e Hematologia do Amazonas, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariane Martins Araujo","family":"Stefani","sequence":"additional","affiliation":[{"name":"Universidade Federal de Goi\u00e1s, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Kiesslich","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Hospitalar de Hemoterapia e Hematologia do Amazonas, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain A","year":"2012","journal-title":"Front Microbiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1590\/S1678-9946201658011","article-title":"Human T-lymphotropic virus 1 (HTLV-1) and human T-lymphotropic virus 2 (HTLV-2) geographical research trends and collaboration networks (1989-2012)","volume":"58","author":"Gonz\u00e1lez-Alcaide G","year":"2016","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1537-2995.1997.37297203532.x","article-title":"Distribution of human T-lymphotropic virus type I among blood donors a nationwide Brazilian study","volume":"37","author":"Galv\u00e3o-Castro B","year":"1997","journal-title":"Transfusion"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fmicb.2012.00389","article-title":"Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis","volume":"3","author":"Yamano Y","year":"2012","journal-title":"Front Microbiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(06)70628-7","article-title":"The HTLV-1 neurological complex","volume":"5","author":"Araujo AQ","year":"2006","journal-title":"Lancet Neurol"},{"key":"ref6","first-page":"259045","article-title":"Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy\/tropical spastic paraparesis recent perspectives","volume":"2012","author":"Saito M","year":"2012","journal-title":"Leuk Res Treatment"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00005072-199307000-00010","article-title":"Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy","volume":"52","author":"Umehara F","year":"1993","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s004010050903","article-title":"Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I associated myelopathy\/tropical spastic paraparesis double staining of immunohistochemistry and polymerase chain reaction in situ hybridization","volume":"96","author":"Matsuoka E","year":"1998","journal-title":"Acta Neuropathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/13550280701258431","article-title":"Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy","volume":"13","author":"Umehara F","year":"2007","journal-title":"J Neurovirol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0022-510X(95)00161-T","article-title":"Characterization of cerebral white matter lesions of HTLV-I-associated myelopathy\/tropical spastic paraparesis in comparison with multiple sclerosis and collagen-vasculitis a semiquantitative MRI study","volume":"133","author":"Godoy AJ","year":"1995","journal-title":"J Neurol Sci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000054813","article-title":"Human T cell lymphotropic virus type 1-associated myelopathy in Sao Paulo, Brazil Epidemiological and clinical features of a university hospital cohort","volume":"21","author":"Milagres AC","year":"2002","journal-title":"Neuroepidemiology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1056\/NEJM198805053181801","article-title":"Detection of human T-cell lymphoma\/leukemia virus type I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy","volume":"318","author":"Bhagavati S","year":"1988","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1590\/S0004-282X1995000200005","article-title":"HTLV-I associated myelopathy in patients from Brazil and Iran neurological manifestations and cerebrospinal fluid findings","volume":"53","author":"Puccioni-Sohler M","year":"1995","journal-title":"Arq Neuropsiquiatr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1365-2710.2001.00358.x","article-title":"Neopterin measurement in clinical diagnosis","volume":"26","author":"Berdowska A","year":"2001","journal-title":"J Clin Pharm Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00011-003-1181-9","article-title":"Potential role of immune system activation-associated production of neopterin derivatives in humans","volume":"52","author":"Hoffmann G","year":"2003","journal-title":"Inflamm Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/BF00810351","article-title":"Neopterin concentrations in serum and cerebrospinal fluid in HTLV-I infected individuals","volume":"239","author":"Ali A","year":"1992","journal-title":"J Neurol"},{"key":"ref17","first-page":"457","article-title":"Neopterin in cerebrospinal fluid a useful marker for diagnosis of","volume":"41","author":"Nomoto M","year":"1991","journal-title":"HTLV-I associated myelopathy\/tropical spastic paraparesis.Neurology"},{"key":"ref18","author":"Osame M","year":"1990"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/13550289509111010","article-title":"HTLV-I associated myelophathy analysis of 213 patients based on clinical features and laboratory findings","volume":"1","author":"Nakagawa M","year":"1995","journal-title":"J Neurovirol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0166-0934(92)90065-L","article-title":"Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of nested PCR products","volume":"40","author":"Tuke PW","year":"1992","journal-title":"J Virol Methods"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/infdis\/168.5.1285","article-title":"Cerebrospinal fluid neopterin concentrations in central nervous system infection","volume":"168","author":"Hagberg L","year":"1993","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Gon\u00e7alves DU","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jnnp.2004.035709","article-title":"Gender influence on the progression of HTLV-I associated myelopathy\/tropical spastic paraparesis","volume":"76","author":"Lima MA","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00042560-199812150-00014","article-title":"HTLV-I-associated myelopathy\/tropical spastic paraparesis in Brazil a nationwide survey. HAM\/TSP Brazilian Study Group","volume":"19","author":"Ara\u00fajo AQ","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1073\/pnas.83.13.4895","article-title":"Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii","volume":"83","author":"Blattner WA","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00052359","article-title":"The epidemiology of HTLV-I infection","volume":"2","author":"Mueller N","year":"1991","journal-title":"Cancer Causes Control"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/oxfordjournals.aje.a115824","article-title":"Human T-lymphotropic virus type I (HTLV- I) seroprevalence in Jamaica I. Demographic determinants","volume":"133","author":"Murphy EL","year":"1991","journal-title":"Am J Epidemiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s13760-013-0194-6","article-title":"Clinical features of HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in northeast Iran","volume":"113","author":"Shoeibi A","year":"2013","journal-title":"Acta Neurol Belg"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1469-8749.2008.03225.x","article-title":"Cerebrospinal fluid neopterin in paediatric neurology a marker of active central nervous system inflammation","volume":"51","author":"Dale RC","year":"2009","journal-title":"Dev Med Child Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.2169\/internalmedicine.52.0869","article-title":"Cerebrospinal fluid neopterin, but not osteopontin, is a valuable biomarker for the treatment response in patients with HTLV-I-associated myelopathy","volume":"52","author":"Nagai M","year":"2013","journal-title":"Intern Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11908-014-0459-0","article-title":"Update on neurological manifestations of HTLV-1 infection","volume":"17","author":"Ara\u00fajo AQ","year":"2015","journal-title":"Curr Infect Dis Rep"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1590\/S0004-282X1995000400009","article-title":"HTLV-I associated tropical spastic paraparesis Cerebral spinal fluid evolutive aspects in 128 cases","volume":"53","author":"Moreno-Carvalho OA","year":"1995","journal-title":"Arq Neuropsiquiatr"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0404.1993.tb04188.x","article-title":"Clinical and demographic features of HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Rio de Janeiro, Brazil","volume":"88","author":"Araujo AQ","year":"1993","journal-title":"Acta Neurol Scand"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2169\/internalmedicine.38.133","article-title":"Adenosine and neopterin levels in cerebrospinal fluid of patients with neurological disorders","volume":"38","author":"Yoshida Y","year":"1999","journal-title":"Intern Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/13550289609146899","article-title":"Therapeutic trial in 200 patients with HTLV-I associated myelopathy\/tropical spastic paraparesis","volume":"2","author":"Nakagawa M","year":"1996","journal-title":"J Neurovirol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00401-004-0924-1","article-title":"Widespread active inflammatory lesions in a case of HTLV-I-associated myelopathy lasting 29 years","volume":"108","author":"Iwasaki Y","year":"2004","journal-title":"Acta Neuropathol"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002479","article-title":"CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"7","author":"Sato T","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s004019900170","article-title":"Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy\/tropical spastic paraparesis inflammatory changes occur simultaneously in the entire central nervous system","volume":"100","author":"Aye MM","year":"2000","journal-title":"Acta Neuropathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00334512","article-title":"An autopsy case of human T lymphotropic virus type I associated myelopathy (HAM) with a duration of 28 years","volume":"81","author":"Sasaki S","year":"1990","journal-title":"Acta Neuropathol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0022-510X(90)90060-Z","article-title":"Pathology of chronic myelopathy associated with HTLV-I infection (HAM\/TSP)","volume":"96","author":"Iwasaki Y","year":"1990","journal-title":"J Neurol Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/jnnp.2008.167155","article-title":"The neurology of HTLV-1 infection","volume":"9","author":"Cooper SA","year":"2009","journal-title":"Pract Neurol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0317167100002420","article-title":"MRI contributes to the differentiation between MS and HTLV-I associated myelopathy in British Columbian coastal natives","volume":"30","author":"Howard AK","year":"2003","journal-title":"Can J Neurol Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0022-510X(91)90192-A","article-title":"Leukoencephalopathy in HTLV-I-associated myelopathy\/tropical spastic paraparesis MRI analysis and a two year follow-up study after corticosteroid therapy","volume":"106","author":"Kira J","year":"1991","journal-title":"J Neurol Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1590\/S0004-282X2012000400004","article-title":"HAM\/TSP association between white matter lesions on magnetic resonance imaging, clinical and cerebrospinal fluid findings","volume":"70","author":"Puccioni-Sohler M","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1089\/aid.2007.0077","article-title":"Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM\/TSP","volume":"23","author":"Morgan DJ","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/13550280500385039","article-title":"Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis","volume":"11","author":"Bagnato F","year":"2005","journal-title":"J Neurovirol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.4067\/S0034-98872006000800010","article-title":"Resonancia magn\u00e9tica de m\u00e9dula espinal y cerebro en el correlato cl\u00ednico de la paraparesia esp\u00e1stica progresiva que se asocia al virus humano linfotr\u00f3pico tipo-I (HTLV-I)","volume":"134","author":"Cervilla J","year":"2006","journal-title":"Rev Med Chil"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v59\/1678-9946-rimtsp-59-e5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T12:45:31Z","timestamp":1719146731000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652017005000203&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":47,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2017]]}},"alternative-id":["S0036-46652017005000203"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946201759005","relation":{},"ISSN":["0036-4665"],"issn-type":[{"value":"0036-4665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}